C16 Galactosylceramide

• Description :

  C16 Galactosylceramide is a sphingolipid compound. C16 Galactosylceramide participates in the physiological processes of lipid metabolism and immune regulation in cells. C16 Galactosylceramide can be used in the study of diabetes[1].

• UNSPSC :

  12352211

• Target :

  Endogenous Metabolite

• Related Pathways :

  Metabolic Enzyme/Protease

• Field of Research :

  Metabolic Disease; Inflammation/Immunology

• Purity :

  98.00

• Smiles :

  CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(CCCCCCCCCCCCCCC)=O)CO[C@@H]1O[C@@H]([C@@H]([C@@H]([C@H]1O)O)O)CO

• Molecular Formula :

  C40H77NO8

• Molecular Weight :

  700.04

• References & Citations :

  [1]Buschard K, et al. Involvement of sulfatide in beta cells and type 1 and type 2 diabetes. Diabetologia. 2005 Oct;48 (10) :1957-62.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported

• CAS Number :

  [34324-89-5]